The only farm in the British Isles growing hemp and CBD extract onsite to create wellness products has shut down after the UK Home Office took action to stop export of its products to the UK.
Please wait, loading...
Please wait, loading...
The only farm in the British Isles growing hemp and CBD extract onsite to create wellness products has shut down after the UK Home Office took action to stop export of its products to the UK.
Steve Oliver Co-Founder at The Canna Consultants discussing Medicinal Cannabis at Malta Med-Tech | November 2022
With Canada and the US leading the way, Europe is looking at its growing cannabis market with excitement, but there are plenty of mistakes to be avoided.
In this episode of the Over The Counter podcast, HBW Insight catches up with cannabis expert Stephen Oliver to talk about the current state of play in Europe’s cannabidiol markets.
CBD products linked to a submitted, rather than validated, novel food application can now remain on the UK market after 31 March, according to new guidance from regulator the Food Standards Agency.
Europe’s hemp industry hit a milestone last week when the European Union’s top court liberated CBD from the jurisdiction of an international drug treaty, declaring that hemp-derived cannabidiol is not a narcotic.
In this video Stephen Oliver, Co-Founder of The Canna Consultants, explains the opportunities and barriers to investment in the European Space during the Med-Cann Virtual Summit. He offers some great advice, addressing the need to think alternatively and adapt to new situations.
Stephen Oliver former Customs Investigator and Matt Lawson Barrister are both experts in the cannabinoid industry, they are the founders of The Canna Consultants and will be speaking at the event on both days.
Stephen Oliver and Matt Lawson are both experts in the cannabinoid industry, they are the founders of The Canna Consultants and will be speaking at the Cannabis Investment Summit World (CISW) which takes place 11-13 of November 2020.
The race for earliest submission of a Novel Food Dossier is a false one. This is especially the case when submissions made thus far, so we understand, lack the appropriate scientific data in respect of end products for which Authorisation is being contended and, in some cases, lack any scientific data in respect of the subject of the application at all.